These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36824298)

  • 21. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
    Bielawiec P; Harasim-Symbor E; Chabowski A
    Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabidiol: State of the art and new challenges for therapeutic applications.
    Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
    Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of the neurological benefits of phytocannabinoids.
    Maroon J; Bost J
    Surg Neurol Int; 2018; 9():91. PubMed ID: 29770251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A validated method for the simultaneous quantification of cannabidiol, Δ
    Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
    Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective evaluation of crib-biting and windsucking behaviours and owner-perceived behavioural traits as risk factors for colic in horses.
    Malamed R; Berger J; Bain MJ; Kass P; Spier SJ
    Equine Vet J; 2010 Nov; 42(8):686-92. PubMed ID: 21039797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
    Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
    ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse.
    Dodman NH; Shuster L; Court MH; Dixon R
    Am J Vet Res; 1987 Feb; 48(2):311-9. PubMed ID: 3826875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of feed on plasma leptin and ghrelin concentrations in crib-biting horses.
    Hemmann KE; Koho NM; Vainio OM; Raekallio MR
    Vet J; 2013 Oct; 198(1):122-6. PubMed ID: 23838207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with behavioural disorders of crib-biting, weaving and box-walking in Swiss horses.
    Bachmann I; Audigé L; Stauffacher M
    Equine Vet J; 2003 Mar; 35(2):158-63. PubMed ID: 12638792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crib-biting in US horses: breed predispositions and owner perceptions of aetiology.
    Albright JD; Mohammed HO; Heleski CR; Wickens CL; Houpt KA
    Equine Vet J; 2009 May; 41(5):455-8. PubMed ID: 19642405
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Procaccia S; Lewitus GM; Lipson Feder C; Shapira A; Berman P; Meiri D
    Front Pharmacol; 2022; 13():894960. PubMed ID: 35548332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
    Fernández-Ruiz J; Sagredo O; Pazos MR; García C; Pertwee R; Mechoulam R; Martínez-Orgado J
    Br J Clin Pharmacol; 2013 Feb; 75(2):323-33. PubMed ID: 22625422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 38. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management factors affecting stereotypies and body condition score in nonracing horses in Prince Edward Island.
    Christie JL; Hewson CJ; Riley CB; McNiven MA; Dohoo IR; Bate LA
    Can Vet J; 2006 Feb; 47(2):136-43. PubMed ID: 16579039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.